Palonosetron with aprepitant plus dexamethasone to prevent chemotherapy-induced nausea and vomiting during gemcitabine/cisplatin in urothelial cancer patients. [electronic resource]
Producer: 20160712Description: 911-4 p. digitalISSN:- 1442-2042
- Adult
- Aged
- Aged, 80 and over
- Antiemetics -- therapeutic use
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Aprepitant
- Carcinoma, Transitional Cell -- drug therapy
- Cisplatin -- administration & dosage
- Deoxycytidine -- administration & dosage
- Dexamethasone -- therapeutic use
- Drug Therapy, Combination
- Female
- Granisetron -- therapeutic use
- Humans
- Isoquinolines -- therapeutic use
- Kidney Neoplasms -- drug therapy
- Male
- Middle Aged
- Morpholines -- therapeutic use
- Nausea -- chemically induced
- Ondansetron -- therapeutic use
- Palonosetron
- Quinuclidines -- therapeutic use
- Retrospective Studies
- Serotonin 5-HT3 Receptor Antagonists -- therapeutic use
- Serotonin Antagonists -- therapeutic use
- Ureteral Neoplasms -- drug therapy
- Urinary Bladder Neoplasms -- drug therapy
- Urologic Neoplasms -- drug therapy
- Vomiting -- chemically induced
- Gemcitabine
No physical items for this record
Publication Type: Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.